Home > Healthcare > Medical Devices > Implantable Devices > Joint Reconstruction Devices Market

Joint Reconstruction Devices Market Share

Report ID: GMI2823
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Joint Reconstruction Devices Market Share

The market is characterized by a competitive landscape, with several key players commanding significant market share. Leading companies such as DePuy Synthes (Johnson & Johnson), Zimmer Biomet, and Smith & Nephew are at the forefront, leveraging their extensive experience and innovative technologies to develop a wide range of joint implants and instruments. These companies focus on research and development to introduce advanced products, including patient-specific implants and robotic-assisted surgical systems, enhancing surgical outcomes and patient satisfaction.

Emerging players are also entering the market, driven by increasing demand for customized and minimally invasive solutions. The market share distribution reflects a trend toward consolidation through mergers and acquisitions, enabling larger firms to expand their portfolios and market presence. As the demand for joint reconstruction procedures continues to grow, these companies are well-positioned to capitalize on the expanding opportunities in the market.

Joint Reconstruction Devices Market Companies

Prominent players operating in the joint reconstruction devices industry include:

Aesculap Implant Systems
Allegra Orthopedic
Amplitude Ortho
Arthrex
CONMED
DJO Global
Exactech
Globus Medical
Integra LifeSciences
Johnson & Johnson
Medacta International
Microport
NuVasive
Smith & Nephew
Stryker
Zimmer Biomet

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global joint reconstruction devices industry was valued at USD 19.6 billion in 2023 and is expected to grow at a 4.5% CAGR from 2024 to 2032, driven by the rising global incidence of joint disorders and injuries.

The knee replacement segment is projected to expand at a 5.1% CAGR, reaching over USD 14.5 billion by 2032, due to factors distinguishing it from other joint replacement segments like hip, shoulder, and ankle.

The North America joint reconstruction devices market accounted for USD 10.5 billion in 2023 and is anticipated to grow at a 3.4% CAGR between 2024 and 2032, driven by the rising incidence of joint-related conditions among the aging population.

Key players in the industry include Aesculap Implant Systems, Allegra Orthopedic, Amplitude Ortho, Arthrex, CONMED, DJO Global, Exactech, Globus Medical, Integra LifeSciences, Johnson & Johnson, and Medacta International.